These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11506622)

  • 1. A new, ring closing metathesis-based synthesis of (-)-fumagillol.
    Boiteau JG; Van de Weghe P; Eustache J
    Org Lett; 2001 Aug; 3(17):2737-40. PubMed ID: 11506622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MetAP-2 inhibitors based on the fumagillin structure. Side-chain modification and ring-substituted analogues.
    Rodeschini V; Boiteau JG; Van de Weghe P; Tarnus C; Eustache J
    J Org Chem; 2004 Jan; 69(2):357-73. PubMed ID: 14725448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and antiangiogenic effects of a series of potent novel fumagillin analogues.
    Lee HW; Cho CS; Kang SK; Yoo YS; Shin JS; Ahn SK
    Chem Pharm Bull (Tokyo); 2007 Jul; 55(7):1024-9. PubMed ID: 17603194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses of fumagillin and ovalicin.
    Yamaguchi J; Hayashi Y
    Chemistry; 2010 Apr; 16(13):3884-901. PubMed ID: 20209516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis and antiangiogenic activity of cyclopentane analogues of fumagillol.
    Jeong BS; Choi NS; Ahn SK; Bae H; Kim HS; Kim D
    Bioorg Med Chem Lett; 2005 Aug; 15(15):3580-3. PubMed ID: 15978809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fumarranol, a rearranged fumagillin analogue that inhibits angiogenesis in vivo.
    Lu J; Chong CR; Hu X; Liu JO
    J Med Chem; 2006 Sep; 49(19):5645-8. PubMed ID: 16970390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise stereocontrolled routes to fumagillol, fumagillin, and TNP-470.
    Vosburg DA; Weiler S; Sorensen EJ
    Chirality; 2003 Feb; 15(2):156-66. PubMed ID: 12520508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel bicyclic oxazolone derivatives as anti-angiogenic agents.
    Perron-Sierra FM; Pierré A; Burbridge M; Guilbaud N
    Bioorg Med Chem Lett; 2002 Jun; 12(11):1463-6. PubMed ID: 12031320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of novel fumagillin and ovalicin analogues.
    Mazitschek R; Huwe A; Giannis A
    Org Biomol Chem; 2005 Jun; 3(11):2150-4. PubMed ID: 15917904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of novel fumagillin analogues as angiogenesis inhibitors.
    Pyun HJ; Fardis M; Tario J; Yang CY; Ruckman J; Henninger D; Jin H; Kim CU
    Bioorg Med Chem Lett; 2004 Jan; 14(1):91-4. PubMed ID: 14684305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Remodeling of fumagillol: discovery of an oxygen-directed oxidative Mannich reaction.
    Grenning AJ; Snyder JK; Porco JA
    Org Lett; 2014 Feb; 16(3):792-5. PubMed ID: 24410175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A stereoselective asymmetric synthesis of antibiotic (-)-fumagillol using claisen rearrangement and intramolecular ester enolate alkylation as key steps.
    Kim D; Ahn SK; Bae H; Kim HS
    Arch Pharm Res; 2005 Feb; 28(2):129-41. PubMed ID: 15789740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic activity of deoxoartemisinin derivatives on chorioallantoic membrane.
    Jung M; Tak J; Chung WY; Park KK
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1227-30. PubMed ID: 16380253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of highly potent fumagillin analogues from homology modeling for a human MetAP-2.
    Han CK; Ahn SK; Choi NS; Hong RK; Moon SK; Chun HS; Lee SJ; Kim JW; Hong CI; Kim D; Yoon JH; No KT
    Bioorg Med Chem Lett; 2000 Jan; 10(1):39-43. PubMed ID: 10636239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymmetric total synthesis and formal total synthesis of the antitumor sesquiterpenoid (+)-eremantholide A.
    Li Y; Hale KJ
    Org Lett; 2007 Mar; 9(7):1267-70. PubMed ID: 17326647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of Luffarin L and 16-epi-Luffarin L Using a Temporary Silicon-Tethered Ring-Closing Metathesis Reaction.
    Urosa A; Marcos IS; Díez D; Padrón JM; Basabe P
    J Org Chem; 2015 Jun; 80(12):6447-55. PubMed ID: 25978124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and evaluation of a series of novel fumagillin analogues.
    Fardis M; Pyun HJ; Tario J; Jin H; Kim CU; Ruckman J; Lin Y; Green L; Hicke B
    Bioorg Med Chem; 2003 Nov; 11(23):5051-8. PubMed ID: 14604668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concise enantio- and diastereoselective total syntheses of fumagillol, RK-805, FR65814, ovalicin, and 5-demethylovalicin.
    Yamaguchi J; Toyoshima M; Shoji M; Kakeya H; Osada H; Hayashi Y
    Angew Chem Int Ed Engl; 2006 Jan; 45(5):789-93. PubMed ID: 16365904
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of ovalicin starting from D-mannose.
    Takahashi S; Hishinuma N; Koshino H; Nakata T
    J Org Chem; 2005 Nov; 70(24):10162-5. PubMed ID: 16292863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fumagalone, a reversible inhibitor of type 2 methionine aminopeptidase and angiogenesis.
    Zhou G; Tsai CW; Liu JO
    J Med Chem; 2003 Jul; 46(16):3452-4. PubMed ID: 12877582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.